Yoseph Shaaltiel Insider Trading $PLX Protalix BioTherapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Yoseph Shaaltiel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Yoseph Shaaltiel. Yoseph Shaaltiel is Executive VP, R&D in Protalix BioTherapeutics, Inc. ($PLX).
Yoseph Shaaltiel in Protalix BioTherapeutics, Inc.
Trading Symbol: PLXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Yoseph Shaaltiel: Executive VP, R&D
Holdings: 585,916 shares
Current Value: $462,874
Latest Transaction: Sep 14 2018
$PLX Market Capitalization: $78.10M
$PLX Previous Close: $0.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Yoseph Shaaltiel in Protalix BioTherapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 14 2018 | PLX | Protalix BioTherap ... | Shaaltiel Yoseph | Executive VP, R&D | Option Exercise | A | 0.56 | 700,000 | 392,000 | 700,000 | |
Sep 16 2016 | PLX | Protalix BioTherap ... | Shaaltiel Yoseph | Executive VP, R&D | Option Exercise | M | 0.00 | 122,162 | 122 | 0 | |
Sep 16 2016 | PLX | Protalix BioTherap ... | Shaaltiel Yoseph | Executive VP, R&D | Buy | M | 0.00 | 122,162 | 122 | 585,916 | 463.8 K to 585.9 K (+26.34 %) |
May 07 2015 | PLX | Protalix BioTherap ... | Shaaltiel Yoseph | Executive VP, R&D | Option Exercise | A | 1.72 | 275,000 | 473,000 | 275,000 | |
Jan 05 2007 | PLX | Protalix BioTherap ... | Shaaltiel Yoseph | Executive VP, R&D | Option Exercise | A | 0.00 | 244,324 | 244 | 244,324 | |
Jan 05 2007 | PLX | Protalix BioTherap ... | Shaaltiel Yoseph | Executive VP, R&D | Grant | A | 0.00 | 2,944,107 | 0 | 2,944,107 | 0 to 2.9 M |
Page: 1